Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Budget Faces $319 Million Cut Under Sequestration

This article was originally published in The Tan Sheet

Executive Summary

The estimated reduction, included in the White House OMB’s report to Congress, is equal to the cost of 900 to 1,200 agency employees, an agency advocate says. The across-the-board cuts loom with the failure of the congressional Super Committee to find $1.2 trillion in cuts over 10 years.

You may also be interested in...



Hamburg Tries To “Cope” With FDA Budget, Pines For Predictability

The commissioner says FDA cannot operate effectively without predictable budgets, just as industry needs consistent FDA policy and actions for successful drug development. Making sequestered user fees available could be accomplished in fiscal 2014 budget negotiations.

Hamburg Tries To “Cope” With FDA Budget, Emphasizes Predictability

The commissioner says FDA cannot operate effectively without predictable budgets, just as industry needs consistent FDA policy and actions for successful drug development. Making sequestered user fees available could be accomplished in fiscal 2014 budget negotiations.

Hamburg Tries To “Cope” With FDA Budget, Emphasizes Predictability

The commissioner says FDA cannot operate effectively without predictable budgets, just as industry needs consistent FDA policy and actions for successful drug development. Making sequestered user fees available could be accomplished in fiscal 2014 budget negotiations.

Related Content

Topics

UsernamePublicRestriction

Register

PS105982

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel